A study in mice showed how T2D drug metformin exerts multiple clinical effects through selective inhibition of mitochondrial ...
NORTH BETHESDA, Md.--(BUSINESS WIRE)--The Foundation for the National Institutes of Health (FNIH) has named Navdeep S. Chandel, Ph.D., of Northwestern University Feinberg School of Medicine, and Vamsi ...
Investigators led by Navdeep Chandel, Ph.D., the David W. Cugell, MD, Professor of Medicine in the Division of Pulmonary and Critical Care, have discovered how the metabolism of mitochondria supports ...
For decades, physicians and scientists thought metformin, the leading type 2 diabetes medication taken by millions worldwide, mainly targets the liver to suppress glucose production. But a new ...
A study found that metformin lowers blood sugar by inhibiting mitochondrial complex I in the gut, not the liver. The drug ...
Before the explosive popularity of GLP-1 weight loss drugs, another "wonder drug," metformin, has been at work lowering blood sugar levels for patients with Type 2 diabetes for decades, but scientists ...
ANN ARBOR, Mich. & CHICAGO--(BUSINESS WIRE)--Penrose TherapeuTx, a pharmaceutical company focused on developing innovative small-molecule therapies for the treatment of advanced cancers, today ...
Complex metabolic pathway diagrams are a hallmark of many biochemistry textbooks. But what do they tell us about disease, physiology, cell signaling, aging, immunity, and gene expression? In a ...
Supplement berberine — ‘nature’s Ozempic’ — appears to engage the same pathway as metformin in the gut Pre-clinical study’s findings help explain several gut-related clinical effects of people who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results